CLINICAL_TRIALS
trial_result
· 2011-08-23
Clinical Trial Update: ALK33-005: A Study of ALKS33 (RDC-0313) in Adults With Alcohol Dependence [Phase 2]
Summary
Phase 2 study ALKS33 (RDC-0313) in adults with alcohol dependence has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alkermes, Inc. | Conditions: Alcohol Dependence | Phase 2 | Status: COMPLETED